Marcel M. Verbeek

Nijmegen, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 207 publications

Neuronal Antibodies in Patients With Atypical Parkinsonism.

Neuronal Antibodies in Patients With Atypical Parkinsonism.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: August 24, 2026

Muscle Regeneration Failure May Lead to Clinical Features of Myopathy in Anti-IgLON5 Disease.

Muscle Regeneration Failure May Lead to Clinical Features of Myopathy in Anti-IgLON5 Disease.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 13, 2026

Incidental DWI-Positive Lesions in 2 Cohorts of CAA and CADASIL: Prevalence, Distribution, and Associations With Clinical Variables.

Incidental DWI-Positive Lesions in 2 Cohorts of CAA and CADASIL: Prevalence, Distribution, and Associations With Clinical Variables.

Journal: Neurology

Published: June 26, 2026

Autoimmune Encephalitis as Treatment-Responsive Cause of Rapidly Progressive Dementia: A Multicenter Prospective Cohort Study.

Autoimmune Encephalitis as Treatment-Responsive Cause of Rapidly Progressive Dementia: A Multicenter Prospective Cohort Study.

Journal: Neurology

Published: May 15, 2026

Stimulating amyloid-β clearance in cerebral amyloid angiopathy with low-sodium oxybate and/or non-invasive vagus nerve stimulation (Clear-Brain): study protocol for a randomised pre-post trial.

Stimulating amyloid-β clearance in cerebral amyloid angiopathy with low-sodium oxybate and/or non-invasive vagus nerve stimulation (Clear-Brain): study protocol for a randomised pre-post trial.

Journal: BMJ open

Published: March 11, 2026

Slow-SPEED: protocol for three randomised trials of remotely delivered exercise to prevent Parkinson's disease.

Slow-SPEED: protocol for three randomised trials of remotely delivered exercise to prevent Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: February 06, 2026

Serum aromatic l-amino acid decarboxylase activity as a biomarker for prodromal and manifest Parkinson's disease.

Serum aromatic l-amino acid decarboxylase activity as a biomarker for prodromal and manifest Parkinson's disease.

Journal: EBioMedicine

Published: January 22, 2026

Diagnosis of primary CNS lymphoma through molecular and immune biomarkers in cerebrospinal fluid (PRICELUS): a multicentre, prospective, cohort study.

Diagnosis of primary CNS lymphoma through molecular and immune biomarkers in cerebrospinal fluid (PRICELUS): a multicentre, prospective, cohort study.

Journal: The Lancet. Haematology

Published: January 08, 2026

Expanding insights into plant rhabdovirus diversity through the discovery of viruses representing 32 putative novel species.

Expanding insights into plant rhabdovirus diversity through the discovery of viruses representing 32 putative novel species.

Journal: Archives of virology

Published: December 15, 2025

Measuring blood-brain barrier dysfunction: a critical appraisal of fluid biomarkers, in vitro models, in vivo imaging, and post-mortem approaches.

Measuring blood-brain barrier dysfunction: a critical appraisal of fluid biomarkers, in vitro models, in vivo imaging, and post-mortem approaches.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: October 20, 2025

Evaluating Basigin as a Potential Biomarker of Blood-Brain Barrier Dysfunction in Cerebral Amyloid Angiopathy.

Evaluating Basigin as a Potential Biomarker of Blood-Brain Barrier Dysfunction in Cerebral Amyloid Angiopathy.

Journal: Neuropathology and applied neurobiology

Published: September 10, 2025

The predictive validity of pontine volume change in spinocerebellar ataxia type 1 (SCA1).

The predictive validity of pontine volume change in spinocerebellar ataxia type 1 (SCA1).

Journal: Neurobiology of disease

Published: July 22, 2025

Showing 1-12 of 207

Last Updated: 09/26/2026